|

Neoadjuvant chemotherapy Clinical Trials

14 actively recruiting trials across 1 location

Also known as: Arm II, NAC, NACT, Neoadjuvant platinum-based doublet chemotherapy, Non

Pipeline

Phase 2: 5Phase 3: 4

Top Sponsors

  • First Affiliated Hospital of Zhejiang University2
  • Case Comprehensive Cancer Center2
  • Zhejiang Cancer Hospital1
  • Yunnan Cancer Hospital1
  • Xijing Hospital1

Indications

  • Cancer13
  • Breast Cancer3
  • Liver Disease1
  • Gall Bladder Carcinoma1
  • Malignant Neoplasm of Bladder1

Other12 trials

AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
Effect of Neoadjuvant Chemotherapy on MRI Accuracy Before Cystectomy
N/A
Feasibility Study of Deep Learning-based MDixon Quant for Quantitative Assessment of Chemotherapy-induced Fatty Liver
N/A
Iparomlimab and Tuvonralimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy for CC
Phase 2
Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB)
Phase 3
Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy
Phase 3
Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer : a Randomized, Open-label, Parallel-controlled, Multi-center Phase III Study (NEOTORCH-BREAST04)
Phase 3
Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer
Phase 2
Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)
Phase 2
Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLC
Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer
Phase 3
Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCC
Phase 2

Cleveland, Ohio2 trials

Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer

Department of Subspecialty Care for Women's Health Women's Health; Division of Gynecologic Oncology, Case Comprehensive Cancer Center

N/A
Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy

Glickman Urological and Kidney Institute, Cleveland Clinic, Case Comprehensive Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.